Genomenon’s Curation and Distribution of Variant Data to Global Clinical Communities Reduces Barriers to Genetic Diagnosis Ann Arbor, MI – Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness, diagnosis, and research for thymidine kinase 2 deficiency (TK2d). Through this collaboration, Genomenon has used its unique combination of AI and team […]

BURLINGAME, Calif. — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, and deepmirror, the AI drug design platform that empowers chemists to focus on more promising drug molecules, today announced a strategic partnership integrating deepmirror with CDD Vault to enhance drug discovery. CDD Vault helps research teams […]

Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition of Molab.ai, a pioneer in artificial intelligence technologies tailored for molecular research. This strategic acquisition will combine Cresset’s powerful computational chemistry platform with Molab.ai’s proven capability to build highly predictive ADME models. It marks a significant […]

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high […]

SAN DIEGO & TAINAN CITY, Taiwan — Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, today announced the signing of a Memorandum of Understanding (MOU) with ChiMei Medical Center (CMMC), a premier medical institution in Taiwan, and Trivator Biomedical Limited, a biomedical advisory firm in Taiwan. This expansion agreement aims to introduce […]

The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project […]

INNOptimizer is using latest Bayesian Optimization algorithms and a broad set of analytical tools to guide optimizations with minimum experimentation needed. Don’t waste time and money with poor experimental design – use INNOptimizer™ to guide your experiments with state-of-the art Bayesian Optimization algorythms.”— Oliver May (GM Synsilico)GELEEN, LIMBURG, NETHERLANDS, July 2, 2025 /EINPresswire.com/ — SynSilico, […]

Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine. MIAMI, – Imagene AI, a pioneer in multi‑modal foundation models for precision medicine, today announced the successful close of a $23 million Series B financing round led by Oracle Chairman and CTO Larry Ellison. This latest infusion brings Imagene AI’s total capital raised […]

Acquisition successfully closed for enterprise value of $5.1 billion Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences Combined capabilities expected to accelerate scientific innovation and drive long-term growth Acquisition is another milestone of Siemens’ ONE Tech Company program expanding Siemens’ offerings into the […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]